Tag: #vaccine

Pfizer’s 25‑valent infant pneumococcal vaccine showed immune responses to all 25 serotypes in Phase 2, company reports

Pfizer's 25‑valent infant pneumococcal vaccine elicited immune responses to all 25 serotypes in Phase 2, with safety similar to Prevnar 20 and stronger serotype 3 responses.

$PFE, #vaccine, #pneumococcal, #pfizer, #pediatrics

EU Authorizes Pfizer-BioNTech XFG-Adapted COVID-19 Vaccine for Ages 6 Months and Up

EU clears Pfizer and BioNTech’s 2026–27 XFG-adapted COVID-19 vaccine for people 6 months and older ahead of the 2026–27 respiratory season.

#covid19, #vaccine, #pfizer, #biontech, #xfg

UK Phase I trial finds AI-designed coronavirus vaccine candidate safe and elicits cross-reactive immune responses

Phase I UK trial: an AI-designed DNA vaccine for sarbecoviruses was safe in 39 adults and induced cross-reactive immune responses, but not proof it protects.

#covid-19, #vaccine, #clinicaltrials, #ai